MTNB - Matinas Biopharma Holdings Inc
Previous close
0.0933
0 0%
Share volume: 2,782,075
Last Updated: Tue 27 Aug 2024 06:00:00 AM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$0.09
0.00
0.00%
Summary score
11%
Profitability
0%
Dept financing
5%
Liquidity
75%
Performance
7%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 31-Dec-2019 - 31-Dec-2023
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-13.52%
Return on assets
-12.12%
Return on sales
-5341%
Return on invested capital
-87.87%
Total debt ratio
14.28%
Debt ratio change over timeo
-1.17%
Current Ratio
15.04%
Quick Ratio
13.06%
Cash Position Ratio
11.39%
Short-term ratios 31-Dec-2022 - 31-Dec-2023
The data are presented for the financials results of the quarters of the last year.
Return on equity
-23.11%
Return on assets
-19.19%
Return on sales
-509.67%
Return on invested capital
-79.44%
Total debt ratio
19.62%
Debt ratio change over timeo
-1.24%
Current Ratio
9.07%
Quick Ratio
9.07%
Cash Position Ratio
8.17%
Last quarter ratios 31-Dec-2023
The data are presented for the financials results of the last quarter.
Return on equity
-27.61%
Return on assets
-23.45%
Return on sales
0%
Return on invested capital
-76.58%
Total debt ratio
23.33%
Debt ratio change over time
-1.3%
Current Ratio
5.93%
Quick Ratio
5.93%
Cash Position Ratio
5.25%
Performance ratios (change over 4 years) 31-Dec-2019 - 31-Dec-2023
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-83.95%
Return on assets
-85.62%
Return on sales
6029.52%
Return on invested capital
2.6%
Total debt ratio
-117.07%
Debt ratio change over time
-1.17%
Current Ratio
-18.54%
Quick Ratio
-15.48%
Cash Position Ratio
-13.75%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | MTNB | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -13.52% | 10.2% | 35.82% | 7.59% |
| Return on assets | -12.12% | 2.89% | 3.31% | 5.76% |
| Return on sales | -5341% | 29.84% | 34.06% | 41.2% |
| Return on invested capital | -87.87% | 3.06% | 5.78% | 20.17% |
| Profitability | 0% | 42% | 67% | 80% |
| Total debt ratio | 14.28% | 91.31% | 89.91% | 26.84% |
| Debt ratio change over time | -1.17% | 295.05% | -10.03% | 1.11% |
| Dept financing | 4% | 50% | 25% | 7% |
| Current Ratio | 9.07% | 0.92% | 2.61% | 5.44% |
| Quick Ratio | 9.07% | 0.8% | 2.24% | 4.68% |
| Cash Position Ratio | 8.17% | 0.31% | 1.72% | 2.92% |
| Liquididy | 75% | 4% | 8% | 19% |
| Short-term ratios | MTNB | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -23.11% | 9.95% | 27.09% | 4.01% |
| Return on assets | -19.19% | 2.47% | 2.17% | 3.36% |
| Return on sales | -509.67% | 24.58% | 28.87% | 32.26% |
| Return on invested capital | -79.44% | 1.71% | 5.84% | 9.7% |
| Profitability | 0% | 51% | 79% | 79% |
| Total debt ratio | 19.62% | 91.02% | 92.9% | 21.89% |
| Debt ratio change over time | -1.24% | 107.3% | -84.55% | 1.71% |
| Dept financing | 5% | 49% | 25% | 6% |
| Current Ratio | 9.07% | 0.92% | 2.61% | 5.44% |
| Quick Ratio | 9.07% | 0.8% | 2.24% | 4.68% |
| Cash Position Ratio | 8.17% | 0.31% | 1.72% | 2.92% |
| Liquididy | 75% | 6% | 19% | 37% |